Guangdong Jiaying Pharmaceutical Co Ltd
002198
Company Profile
Business description
Guangdong Jiaying Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is mainly engaged in the research and development, production, and sales of pharmaceuticals. The company's main products cover throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal. Its product portfolio consists of Shuangliao Houfeng San, Chongganling Tablets, Jiegu Qili Tablets (Capsules), Shufeng Huoluo Tablets, Tiaojing Huoxue Tablets, etc.
Contact
Dongsheng Industrial Park
Zone B
Guangdong Province
Meizhou514021
CHNT: +86 7532321916
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2026
Employees
594
Stocks News & Analysis
stocks
This onetime AI market darling is now surprisingly undervalued
This AI leader qualifies as a GARP stock today.
stocks
Undervalued ASX miner hits production homerun
Record volumes, lower costs and reduced debt underpin a stronger earnings outlook for ASX miner.
stocks
Meta earnings: AI-driven improvements in top line fail to impress investors
We reiterate our fair value estimate for wide-moat Meta and view the after-market selloff as an overreaction
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,137.00 | 70.20 | -0.76% |
| CAC 40 | 8,553.06 | 67.42 | 0.79% |
| DAX 40 | 25,705.77 | 93.74 | 0.37% |
| Dow JONES (US) | 52,208.06 | 613.92 | 1.19% |
| FTSE 100 | 10,917.61 | 20.34 | 0.19% |
| HKSE | 25,884.43 | 25.55 | 0.10% |
| NASDAQ | 25,122.18 | 679.24 | 2.78% |
| Nikkei 225 | 64,362.02 | 2,494.59 | 4.03% |
| NZX 50 Index | 13,699.28 | 63.50 | -0.46% |
| S&P 500 | 7,437.63 | 121.48 | 1.66% |
| S&P/ASX 200 | 8,976.80 | 73.10 | -0.81% |
| SSE Composite Index | 3,832.26 | 27.57 | 0.72% |